5HT(3)RA plus dexamethasone plus aprepitant for controlling delayed chemotherapy‐induced nausea and vomiting in colorectal cancer

Delayed chemotherapy‐induced nausea and vomiting (CINV) is not well controlled in colorectal cancer (CRC) patients undergoing oxaliplatin (L‐OHP)‐based chemotherapy. Whether neurokinin‐1 receptor antagonist addition to a first‐generation 5HT(3) antagonist (1st 5‐HT(3)RA) and dexamethasone (DEX) is b...

Descripción completa

Detalles Bibliográficos
Autores principales: Hayashi, Toshinobu, Shimokawa, Mototsugu, Matsuo, Koichi, Nishimura, Junichi, Iihara, Hirotoshi, Nakano, Takafumi, Egawa, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893986/
https://www.ncbi.nlm.nih.gov/pubmed/33274555
http://dx.doi.org/10.1111/cas.14757

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893986/
https://www.ncbi.nlm.nih.gov/pubmed/33274555
http://dx.doi.org/10.1111/cas.14757

Ejemplares similares